Anemia / 2012 / Article / Fig 3

Clinical Study

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

Figure 3

Mean changes in hemoglobin, ferritin, and TSAT from baseline to the highest value between baseline and end of study or time of intervention for subjects in the multidose study (mITT population). values for the differences between SMC groups versus FCM (determined by one-way ANOVA) are shown above the bars.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.